Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03558503
Brief Title: A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (OPTIMA II)

First Submitted : May 8, 2018
First Submitted that Met QC Criteria : June 3, 2018
First Posted : June 15, 2018

Certification/Extension First Submitted : December 9, 2020
Certification/Extension First Submitted that Met QC Criteria : December 9, 2020
Certification/Extension First Posted : December 11, 2020

Last Update Submitted that Met QC Criteria : December 9, 2020
Last Update Posted : December 11, 2020